Cigna Group (CI) – Investment Analysts’ Recent Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Cigna Group (NYSE: CI) in the last few weeks:

• 11/25/2025 – Cigna Group had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 11/19/2025 – Cigna Group had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 11/13/2025 – Cigna Group had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 11/12/2025 – Cigna Group was given a new $294.00 price target on by analysts at UBS Group AG.
• 11/12/2025 – Cigna Group had its price target lowered by analysts at Sanford C. Bernstein from $346.00 to $294.00. They now have a “market perform” rating on the stock.
• 11/8/2025 – Cigna Group was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 11/5/2025 – Cigna Group had its price target lowered by analysts at Wells Fargo & Company from $354.00 to $300.00. They now have an “equal weight” rating on the stock.
• 11/4/2025 – Cigna Group had its “buy” rating reaffirmed by analysts at Cowen Inc.
• 11/4/2025 – Cigna Group had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $370.00 to $330.00. They now have a “buy” rating on the stock.
• 11/4/2025 – Cigna Group had its price target lowered by analysts at TD Cowen from $387.00 to $333.00. They now have a “buy” rating on the stock.
• 11/4/2025 – Cigna Group had its price target lowered by analysts at JPMorgan Chase & Co. from $428.00 to $375.00. They now have an “overweight” rating on the stock.
• 11/3/2025 – Cigna Group had its “strong-buy” rating reaffirmed by analysts at Raymond James Financial, Inc..
• 11/3/2025 – Cigna Group had its “buy” rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a $310.00 price target on the stock.
• 11/3/2025 – Cigna Group had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $415.00 to $301.00. They now have a “buy” rating on the stock.
• 11/3/2025 – Cigna Group was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating.
• 10/31/2025 – Cigna Group had its “overweight” rating reaffirmed by analysts at Morgan Stanley. They now have a $355.00 price target on the stock.
• 10/31/2025 – Cigna Group had its price target lowered by analysts at Barclays PLC from $383.00 to $300.00. They now have an “overweight” rating on the stock.
• 10/31/2025 – Cigna Group had its price target lowered by analysts at Leerink Partners from $300.00 to $270.00.
• 10/31/2025 – Cigna Group had its price target lowered by analysts at Cantor Fitzgerald from $365.00 to $325.00.
• 10/31/2025 – Cigna Group had its price target lowered by analysts at Guggenheim from $350.00 to $309.00.
• 10/31/2025 – Cigna Group had its price target lowered by analysts at Truist Financial Corporation from $375.00 to $310.00.
• 10/15/2025 – Cigna Group had its price target lowered by analysts at Wolfe Research from $345.00 to $325.00. They now have an “outperform” rating on the stock.
• 10/14/2025 – Cigna Group is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $370.00 price target on the stock.
• 10/14/2025 – Cigna Group is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $370.00 price target on the stock.
• 10/8/2025 – Cigna Group had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 10/7/2025 – Cigna Group had its price target raised by analysts at Wells Fargo & Company from $340.00 to $354.00. They now have an “equal weight” rating on the stock.
• 10/3/2025 – Cigna Group was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be paid a $1.51 dividend. The ex-dividend date is Thursday, December 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. Cigna Group’s payout ratio is 26.64%.

Insider Activity

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at $15,354,600. This represents a 9.49% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO David Cordani bought 4,134 shares of Cigna Group stock in a transaction dated Monday, November 3rd. The shares were acquired at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the purchase, the chief executive officer owned 157,935 shares in the company, valued at approximately $38,201,317.80. The trade was a 2.69% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 0.70% of the company’s stock.

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.